Lucira Health, Inc.
LHDXDelisted Apr 12, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652724
Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Lucira Health, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 40 | 38 | −2 |
| Shares | 23.4M | 22.7M | −770.9K (−3.3%) |
| Value | $83.7M | $42.2M | −$41.5M (−49.6%) |
New holders (5)
Institutions that held Lucira Health, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 326,198 | $607.0K | 0.00% |
| Choice Wealth Advisors, LLC | 97,518 | $181.0K | 0.15% |
| Bridgeway Capital Management, LLC | 87,700 | $163.0K | 0.00% |
| Renaissance Technologies LLC | 41,800 | $78.0K | 0.00% |
| Prudential Financial Inc | 17,200 | $32.0K | 0.00% |
Sold out (7)
Institutions that held Lucira Health, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Silverarc Capital Management, LLC | 310,734 | $1.11M |
| Atom Investors LP | 85,921 | $307.0K |
| Qube Research & Technologies Ltd | 58,790 | $210.0K |
| 683 Capital Management, LLC | 41,629 | $149.0K |
| Man Group plc | 12,415 | $44.0K |
| Johnson Financial Group, Inc. | 10,000 | $36.0K |
| Gemmer Asset Management LLC | 3,000 | $10.0K |